Adherence in patients taking methotrexate for arthritis

The aim of this study is to understand why people decide whether or not to take methotrexate when it is prescribed for arthritis.

What's involved?

We are currently conducting a study for people who have been prescribed methotrexate for arthritis. We are interested in finding out the reasons people have for deciding whether to take methotrexate when they have been prescribed it for arthritis.

It involves a single interview of up to 1 hour with a researcher from the University of Auckland. This can be done in person at the Greenlane Clinical Centre or Clinical Research Centre at the University of Auckland, or alternatively can be done online over Zoom. In the interview you will be asked about your reasons for taking, or not taking, methotrexate. This study is led by Professor Nicola Dalbeth and Dr Rachel Murdoch from the Department of Medicine at the University of Auckland. At the completion of the interview, participants will receive a $50 MTA (petrol) voucher.

If you are interested in taking part or have any questions, please contact the researchers of the study at They can answer any questions you may have about the study without any obligation to take part.

Eligibility criteria

You're invited to participate in this research if you meet the following criteria:

  • Aged 18 years or older
  • Diagnosed by a rheumatologist with inflammatory arthritis (such as rheumatoid arthritis or psoriatic arthritis)
  • Prescribed oral methotrexate within the past 6 months

Contact details

Primary Investigator

Dr Rachel Murdoch
Phone: 09 923 4139

Head of Department and Co-investigator

Professor Nicola Dalbeth
Phone: 09 923 2568

Further information

Ethics approval: approved by the Central Health and Disability Ethics Committee (HDEC) on 25 August 2023.

Ethics reference: 2023 EXP 18153.